Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients
European Journal of Internal Medicine · 2024
DOI: 10.1016/j.ejim.2024.07.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Luca Liberale und 19 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Ospedale Policlinico San Martino, Genoa - Italian Cardiovascular Network, 10 Largo Rosanna Benzi, 16132 Genoa, Italy; First Clinic of Internal …. Hauptthemen laut MEDLINE: Resistin, Peroxidase, Renal Dialysis, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
BACKGROUND: In patients with kidney failure (KF) undergoing dialysis, neutrophils are dysfunctionally activated. Such chronic activation does not correspond to increased protection against infections and is thought to cause direct vascular damage accounting for the higher incidence of cardiovascular (CV) events. We hypothesized that circulating levels of neutrophil degranulation products (i.e. myeloperoxidase (MPO) and resistin) can predict overall and CV-specific mortality in dialysis patients. METHODS: MPO and resistin levels were assessed in plasma samples from n = 1182 dialysis patients who were followed-up for median 2.9 years (IQR: 1.7-4.2). RESULTS: Patients were 65 ± 14 (SD) years old and 36 % women. Median value of MPO and resistin were 78 ng/mL (IQR: 54 - 123) and 72 ng/mL (IQR: 46 - 110), respectively. MPO and resistin levels correlated with biomarkers of organ damage, nutritional status and inflammation. Both MPO and resistin levels predicted all-cause mortality even after adjustment for traditional risk factors and inflammation, nutritional and KF-related indexes (MPO, HRfor 1 ln unit increase: 1.26, 95 %CI 1.11 - 1.42, P < 0.001; Resistin, HRfor 1 ln unit increase: 1.25, 95 %CI 1.09 - 1.44, P = 0.001). Similarly, their predictive ability held true also for CV death (MPO, HRfor 1 ln unit increase: 1.19, 95 %CI 1.01 - 1.41, P = 0.04; Resistin, HRfor 1 ln unit increase: 1.29, 95 %CI 1.07 - 1.56, P = 0.007). CONCLUSION: Plasma levels of MPO and resistin correlate with prospective overall and CV-specific mortality risk in KF patients undergoing dialysis and might be useful prognostic tools. Mediators of inflammation may be potential target to improve survival of those patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Ospedale Policlinico San Martino, Genoa - Italian Cardiovascular Network, 10 Largo Rosanna Benzi, 16132 Genoa, Italy; First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 vial…
- Clinical Epidemiology of Renal Disease and Hypertension Unit. Reggio Cal CNR Unit of the Pisa CNR Institute of Clinical Physiology, Italy.
- CNR-IFC, Rome, Italy.
- First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy.
- Clinical Epidemiology of Renal Disease and Hypertension Unit. Reggio Cal CNR Unit of the Pisa CNR Institute of Clinical Physiology, Italy; Nephrology, Hypertension and Renal Transplantation Unit, Grande Ospedale Metropo…
- Renal Research Institute, New York, USA; IPNET, c/o Nefrologia del Grande Ospedale Metropolitano, Reggio Cal. Italy.
Förderung
- Ministero della Salute
Zitieren
APA
Liberale, L., Torino, C., Pizzini, P., Mezzatesta, S., D'Arrigo, G., Gori, M., Carbone, F., Schiavetta, E., Cugno, V., Cabri, M., Sgura, C., Maioli, E., Mbarga, D., Rubini, G., Tirandi, A., Ramoni, D., Mallamaci, F., Tripepi, G., Zoccali, C., & Montecucco, F. (2024). Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.07.013
Vancouver
Liberale L, Torino C, Pizzini P, Mezzatesta S, D'Arrigo G, Gori M, et al. Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.07.013
BibTeX
@article{Liberale2024,
author = {Liberale, Luca and Torino, Claudia and Pizzini, Patrizia and Mezzatesta, Sabrina and D'Arrigo, Graziella and Gori, Mercedes and Carbone, Federico and Schiavetta, Elisa and Cugno, Valeria and Cabri, Mara and Sgura, Cosimo and Maioli, Elia and Mbarga, Danielle and Rubini, Gianluca and Tirandi, Amedeo and Ramoni, Davide and Mallamaci, Francesca and Tripepi, Giovanni and Zoccali, Carmine and Montecucco, Fabrizio},
title = {Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients},
journal = {European Journal of Internal Medicine},
year = {2024},
doi = {10.1016/j.ejim.2024.07.013}
}
EUVIMED